NCT03487848View on ClinicalTrials.gov

Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

October 18, 2018

Study Completion Date

September 17, 2020

Conditions
Hepatitis CChronic Hepatitis
Interventions
DRUG

Daclatasvir

Specified dose on specified days for specified duration

DRUG

Sofosbuvir

Specified dose on specified days for specified duration

Trial Locations (2)

3052

Local Institution, Melbourne

08950

Local Institution, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03487848 - Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection | Biotech Hunter | Biotech Hunter